Konstantinopoulos, Panagiotis A. http://orcid.org/0000-0002-1032-1479
Matulonis, Ursula A.
Article History
Received: 8 March 2023
Accepted: 17 July 2023
First Online: 31 August 2023
Competing interests
: U.A.M. declares participation in scientific advisory boards (Allarity, NextCure, Trillium, Agenus, ImmunoGen, Novartis, Boerhinger Ingelheim, the Ovarian Cancer Research Alliance, MorphoSys, CureLab, Eisai and ProfoundBio) and participation in a data safety-monitoring board (Alkermes and Symphogen), consulting (Merck, GSK, AstraZeneca) and a speakers bureau (Med Learning Group). P.A.K. declares participation in scientific advisory boards (Alkermes, AstraZeneca, GSK, BMS, Repare, Artios, Kadmon, ImmunoGen, Bayer, Merck, Merck KGaA and Pfizer) and a scientific steering committee (AstraZeneca).